Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000375·Evoke Pharma Inc
Schedule 13G ownership disclosure
EVOKE PHARMA INC
Common Stock, par value $0.0001 · CUSIP: 30049G302
Event date: 2025-03-31
- Filing-level shares
- 61,274.00
- Percent of class
- 3.9%
- Lytton, Laurence W.
Shares: 61,274.00 · Class: 3.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000375
- Form type
- SCHEDULE 13G/A
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership